Lanean...
Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy
RNA interference (RNAi) offers a promising therapeutic approach for dominant genetic disorders that involve gain-of-function mechanisms. One candidate disease for RNAi therapy application is myotonic dystrophy type 1 (DM1), which results from toxicity of a mutant mRNA. DM1 is caused by expansion of...
Gorde:
| Argitaratua izan da: | Hum Mol Genet |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Oxford University Press
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4527493/ https://ncbi.nlm.nih.gov/pubmed/26082468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/hmg/ddv219 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|